"10.1371_journal.pone.0085897","plos one","2014-01-20T00:00:00Z","Carlo Barone; Carmine Pinto; Nicola Normanno; Lorenzo Capussotti; Francesco Cognetti; Alfredo Falcone; Lorenzo Mantovani","Medical Oncology Unit, Gemelli Hospital, Rome, Italy; Medical Oncology Unit, S.Orsola-Malpighi Hospital, Bologna, Italy; Cellular Biology and Biotherapies Unit, Pascale Foundation, Naples, Italy; General and Oncological Surgery, Umberto I Hospital, Turin, Italy; Medical Oncology Department, Regina Elena Hospital, Rome, Italy; Oncology, Transplantations and New Medical Technologies Department, Santa Chiara Hospital, Pisa, Italy; Clinical Medicine and Surgery Unit, Federico II University of Naples, Naples, Italy","Analyzed the data: CB CP NN LC FC AF LM. Wrote the paper: CB CP NN LM. Conceived and designed the questionnaires: CB CP NN LC FC AF LM.","The authors have the following interests: Merck Serono S.p.A. (http://www.merckserono.com/it/index.html) has given support to the scientific committee to finance the development of field work for the Delphi survey part of the study. Support by Merck Serono S.p.A. was restricted to logistic expenses of the authors. This does not alter the authors adherence to all the PLOS ONE policies an sharing data and materials.","2014","01","Carlo Barone","CB",7,TRUE,7,NA,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
